Stocksigma LogoStocksigma Logo

Poly Medicure Delivers Strong Q2 FY27 Revenue Growth Driven by International Expansion

Poly Medicure reported a 30.8% YoY rise in consolidated Q2 FY27 revenue to Rs 580.5 crore (organic growth at 16.3%), supported by 35.0% YoY growth in

Poly Medicure Delivers Strong Q2 FY27 Revenue Growth Driven by International Expansion

Poly Medicure Ltd 路 Investor Presentation 路 05 Nov 2026, 8:14 pm

Poly Medicure Delivers Strong Q2 FY27 Revenue Growth Driven by International Expansion Poly Medicure reported a 30.8% YoY rise in consolidated Q2 FY27 revenue to Rs 580.5 crore (organic growth at 16.3%), supported by 35.0% YoY growth in international sales and 22.0% in domestic markets. Consolidated operating EBITDA grew 20.1% YoY to Rs 139.1 crore with a 24.0% margin, while PAT rose 3.6% YoY to Rs 95.1 crore. Non-infusion segments expanded to 51% of revenue in H1 FY27. Liquidity remained robust with Rs 839.1 crore in cash and cash equivalents as of 30th Sep'26.

Original exchange filing (PDF)

More announcements from Poly Medicure Ltd

All Poly Medicure Ltd announcements